Twenty years on, survivors of testicular cancer still have large amounts of
platinum circulating in their blood, from their chemotherapy. A team from the
University of Groningen in the Netherlands examined 61 men who had been treated
with the platinum-containing drug cisplatin. Between 10 and 20 years later the
men had an average of 65 picograms per gram of plasma. Among 20 controls, who
survived testicular cancer without chemotherapy, 18 had no platinum and two had
only traces (The Lancet, vol 355, p 1075). The team says the drug’s
persistence justifies research into long-term side effects.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features

Life
Fossil fruits show flowering plants flourished in time of dinosaurs
News

Environment
Can home batteries help save the climate and save you money?
News

91É«Ç鯬
We’ve uncovered a master gene that switches on human development
News

Environment
The race to understand how and when Thwaites glacier will collapse
Features
Popular articles
Trending New Scientist articles
1
Woman with Alzheimer's starts conversing again after taking psilocybin
2
If you aren't terrified by this heatwave, you should be
3
Lost books by ancient philosophers recovered from 'unreadable' scrolls
4
The race to understand how and when Thwaites glacier will collapse
5
Our verdict on The Selfish Gene: An unpopular piece of popular science
6
Where, when and how to watch the 2026 solar eclipse
7
How menopause radically changes the brain – and what happens after
8
You should turn off fans when it's too hot – but how hot is too hot?
9
We’ve uncovered a master gene that switches on human development
10
The surprising ways your brain changes from your 20s to your 40s